Cosyntropin vs Neurotensin
Head-to-head comparison of Cosyntropin (Cosyntropin (ACTH 1-24)) and Neurotensin (Neurotensin) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Cosyntropin | Neurotensin |
|---|---|---|
| Category | Pain Management | Pain Management |
| Full Name | Cosyntropin (ACTH 1-24) | Neurotensin |
| Molecular Weight | 2933.3 Da | 1672.94 |
| Half-Life | ~10 min | minutes |
| Amino Acids | 24 | 13 |
| Typical Dose | 0.25 mg IV/IM diagnostic dose|off-label headache protocols vary | N/A|N/A |
| Route | IV|IM | Intranasal/experimental injection |
| Purity | ≥98% | ≥98% |
| Studies Count | 61 | 81 |
| Research Status | Clinical research | Pre-clinical |
Cosyntropin Benefits
- ✓refractory migraine
- ✓anti-inflammatory signaling
- ✓headache rescue research
Neurotensin Benefits
- ✓antinociceptive signaling
- ✓descending pain modulation
- ✓preclinical pain research
Cosyntropin Dosing
0.25 mg IV/IM|1 mg IV/IM
Neurotensin Dosing
N/A|N/A
Cosyntropin Side Effects
- ⚠flushing
- ⚠nausea
Neurotensin Side Effects
- ⚠hypotension
- ⚠nausea
- ⚠hypothermia
Research Overview
Cosyntropin
Cosyntropin is not a standard pain drug, but it appears in headache literature because ACTH analogs can help some patients with difficult migraine attacks. The analgesic rationale is partly tied to steroidogenic and anti-inflammatory effects.
Neurotensin
Neurotensin has reproducible analgesic and neuromodulatory effects in preclinical studies, especially in inflammatory and neuropathic pain paradigms. It is not a standard clinical analgesic, but it is a real non-opioid peptide with pain-relevant biology.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.